Erratum: A preliminary double-blind, placebo-controlled randomized study of baclofen effects in alcoholic smokers (Psychopharmacology 10.1007/s00213-014-3652-9);A preliminary double-blind, placebo-controlled randomized study of baclofen effects in alcoholic smokers

Psychopharmacology

Volumn 232, Issue 1, 2015, Pages 233-243

  Leggio, Lorenzo ^a,b,c   Zywiak, William H ^d,e,f   Edwards, Steven M ^g   Tidey, Jennifer W ^f   Swift, Robert M ^f,h,i   Kenna, George A ^f  

^a NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM   (United States)

^b NATIONAL INSTITUTE ON DRUG ABUSE   (United States)

^c BROWN UNIVERSITY   (United States)

^d Pacific Institute for Research and Evaluation   (United States)

^e BUTLER HOSPITAL   (United States)

^f BROWN UNIVERSITY   (United States)

^g UNIVERSITY OF NEBRASKA LINCOLN   (United States)

^h PROVIDENCE VETERANS AFFAIRS MEDICAL CENTER   (United States)

ⁱ ROGER WILLIAMS MEDICAL CENTER   (United States)

Author keywords

Alcoholism; Baclofen; Comorbidity; Smoking

Indexed keywords

BACLOFEN;

ADULT; ALCOHOLISM; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRINKING BEHAVIOR; FEMALE; FOLLOW UP; HUMAN; MALE; MIDDLE AGED; PILOT STUDY; PSYCHOLOGY; RANDOMIZED CONTROLLED TRIAL; SMOKING; TREATMENT OUTCOME;

ADULT; ALCOHOL DRINKING; ALCOHOLICS; ALCOHOLISM; BACLOFEN; DOUBLE-BLIND METHOD; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; PILOT PROJECTS; SMOKING; TREATMENT OUTCOME;

EID: 84928781239     PISSN: 00333158     EISSN: 14322072     Source Type: Journal    
DOI: 10.1007/s00213-015-3916-z     Document Type: Erratum

References (82)

1. Addolorato G, Caputo F, Capristo E, Colombo G, Gessa GL, Gasbarrini G (2000) Ability of baclofen in reducing alcohol craving and intake: II - preliminary clinical evidence. Alcohol Clin Exp Res 24:67-71
2. Addolorato G, Caputo F, Capristo E, Domenicali M, Bernardi M, Janiri L, Agabio R, Colombo G, Gessa GL, Gasbarrini G (2002a) Baclofen efficacy in reducing alcohol craving and intake: a preliminary double-blind randomized controlled study. Alcohol Alcohol 37:504-508
3. Addolorato G, Caputo F, Capristo E, Janiri L, Bernardi M, Agabio R, Colombo G, Gessa GL, Gasbarrini G (2002b) Rapid suppression of alcohol withdrawal syndrome by baclofen. Am J Med 112:226-229
4. Addolorato G, Leggio L, Abenavoli L, Agabio R, Caputo F, Capristo E, Colombo G, Gessa GL, Gasbarrini G (2006) Baclofen in the treatment of alcohol withdrawal syndrome: a comparative study vs diazepam. Am J Med 119(276):e213-e278
5. Addolorato G, Leggio L, Ferrulli A, Cardone S, Vonghia L, Mirijello A, Abenavoli L, D'Angelo C, Caputo F, Zambon A, Haber PS, Gasbarrini G (2007) Effectiveness and safety of baclofen for maintenance of alcohol abstinence in alcohol-dependent patients with liver cirrhosis: randomised, double-blind controlled study. Lancet 370:1915-1922
6. Addolorato, G., Leggio, L., Ferrulli, A., Cardone, S., Bedogni, G., Caputo, F., Gasbarrini, G., Landolfi, R., Baclofen Study, G., 2011. Dose-response effect of baclofen in reducing daily alcohol intake in alcohol dependence: secondary analysis of a randomized, double-blind, placebo-controlled trial. Alcohol and Alcoholism 46, 312-317
7. Anstrom KK, Cromwell HC, Markowski T, Woodward DJ (2003) Effect of baclofen on alcohol and sucrose self-administration in rats. Alcohol Clin Exp Res 27:900-908
8. Anton RF, Moak DH, Latham P (1995) The Obsessive Compulsive Drinking Scale: a self-rated instrument for the quantification of thoughts about alcohol and drinking behavior. Alcohol Clin Exp Res 19:92-99
9. Anton RF, O'Malley SS, Ciraulo DA, Cisler RA, Couper D, Donovan DM, Gastfriend DR, Hosking JD, Johnson BA, LoCastro JS, Longabaugh R, Mason BJ, Mattson ME, Miller WR, Pettinati HM, Randall CL, Swift R, Weiss RD, Williams LD, Zweben A, COMBINE Study Research Group (2006) Combined pharmacotherapies and behavioral interventions for alcohol dependence: the COMBINE study: a randomized controlled trial. JAMA 295:2003-2017
10. Baltieri DA, Daro FR, Ribeiro PL, Andrade AG (2009) Effects of topiramate or naltrexone on tobacco use among male alcohol-dependent outpatients. Drug Alcohol Depend 105:33-41
11. Bertholet N, Gaume J, Faouzi M, Gmel G, Daeppen JB (2012) Predictive value of readiness, importance, and confidence in ability to change drinking and smoking. BMC Public Health 12:708
12. Besheer J, Lepoutre V, Hodge CW (2004) GABA(B) receptor agonists reduce operant ethanol self-administration and enhance ethanol sedation in C57BL/6J mice. Psychopharmacology (Berl) 174:358-366
13. Biener L, Abrams DB (1991) The contemplation ladder: validation of a measure of readiness to consider smoking cessation. Health Psychol: Official Journal of the Division of Health Psychology, American Psychological Association 10:360-365
14. Bohn MJ, Krahn DD, Staehler BA (1995) Development and initial validation of a measure of drinking urges in abstinent alcoholics. Alcohol Clin Exp Res 19:600-606
15. Bowery NG, Hudson AL, Price GW (1987) GABAA and GABAB receptor site distribution in the rat central nervous system. Neuroscience 20:365-383
16. Chaudhri N, Woods CA, Sahuque LL, Gill TM, Janak PH (2013) Unilateral inactivation of the basolateral amygdala attenuates context-induced renewal of Pavlovian-conditioned alcohol-seeking. Eur J Neurosci 38:2751-2761
17. Colombo G, Agabio R, Carai MA, Lobina C, Pani M, Reali R, Addolorato G, Gessa GL (2000) Ability of baclofen in reducing alcohol intake and withdrawal severity: I-preclinical evidence. Alcohol Clin Exp Res 24:58-66
18. Colombo G, Serra S, Brunetti G, Atzori G, Pani M, Vacca G, Addolorato G, Froestl W, Carai MA, Gessa GL (2002) The GABA(B) receptor agonists baclofen and CGP 44532 prevent acquisition of alcohol drinking behaviour in alcohol-preferring rats. Alcohol Alcohol 37:499-503
19. Colombo G, Serra S, Brunetti G, Vacca G, Carai MA, Gessa GL (2003a) Suppression by baclofen of alcohol deprivation effect in Sardinian alcohol-preferring (sP) rats. Drug Alcohol Depend 70:105-108
20. Colombo G, Vacca G, Serra S, Brunetti G, Carai MA, Gessa GL (2003b) Baclofen suppresses motivation to consume alcohol in rats. Psychopharmacology (Berl) 167:221-224
21. Colombo G, Serra S, Vacca G, Carai MA, Gessa GL (2006) Baclofen-induced suppression of alcohol deprivation effect in Sardinian alcohol-preferring (sP) rats exposed to different alcohol concentrations. Eur J Pharmacol 550:123-126
22. COMBINE Study Research Group (2003) Testing combined pharmacotherapies and behavioral interventions in alcohol dependence: rationale and methods. Alcohol Clin Exp Res 27:1107-1122
23. Cooney JL, Cooney NL, Pilkey DT, Kranzler HR, Oncken CA (2003) Effects of nicotine deprivation on urges to drink and smoke in alcoholic smokers. Addiction 98:913-921
24. Cooney NL, Cooney JL, Perry BL, Carbone M, Cohen EH, Steinberg HR, Pilkey DT, Sevarino K, Oncken CA, Litt MD (2009) Smoking cessation during alcohol treatment: a randomized trial of combination nicotine patch plus nicotine gum. Addiction 104:1588-1596
25. Corrigall WA, Coen KM, Adamson KL, Chow BL, Zhang J (2000) Response of nicotine self-administration in the rat to manipulations of mu-opioid and gamma-aminobutyric acid receptors in the ventral tegmental area. Psychopharmacology (Berl) 149:107-114
26. Corrigall WA, Coen KM, Zhang J, Adamson KL (2001) GABA mechanisms in the pedunculopontine tegmental nucleus influence particular aspects of nicotine self-administration selectively in the rat. Psychopharmacology (Berl) 158:190-197
27. Cousins MS, Stamat HM, de Wit H (2001) Effects of a single dose of baclofen on self-reported subjective effects and tobacco smoking. Nicotine Tobacco Research: Off J Society Research Nicotine Tobacco 3:123-129
28. Cox LS, Tiffany ST, Christen AG (2001) Evaluation of the brief questionnaire of smoking urges (QSU-brief) in laboratory and clinical settings. Nicotine Tobacco Research: Off J Society Research Nicotine Tobacco 3:7-16
29. Daoust M, Saligaut C, Lhuintre JP, Moore N, Flipo JL, Boismare F (1987) GABA transmission, but not benzodiazepine receptor stimulation, modulates ethanol intake by rats. Alcohol 4:469-472
30. Del Boca FK, Kranzler HR, Brown J, Korner PF (1996) Assessment of medication compliance in alcoholics through UV light detection of a riboflavin tracer. Alcohol Clin Exp Res 20:1412-1417
31. Drummond DC (2000) What does cue-reactivity have to offer clinical research? Addiction 95(Suppl 2):S129-S144
32. Duke AN, Kaminski BJ, Weerts EM (2014) Baclofen effects on alcohol seeking, self-administration and extinction of seeking responses in a within-session design in baboons. Addict Biol 19:16-26
33. Fagerstrom KO, Schneider NG (1989) Measuring nicotine dependence: a review of the Fagerstrom Tolerance Questionnaire. J Behav Med 12:159-182
34. Falk DE, Yi HY, Hiller-Sturmhofel S (2006) An epidemiologic analysis of co-occurring alcohol and tobacco use and disorders: findings from the National Epidemiologic Survey on Alcohol and Related Conditions. Alcohol Research Health: J National Institute Alcohol Abuse Alcoholism 29:162-171
35. Fattore L, Cossu G, Martellotta MC, Fratta W (2002) Baclofen antagonizes intravenous self-administration of nicotine in mice and rats. Alcohol Alcohol 37:495-498
36. Fattore L, Spano MS, Cossu G, Scherma M, Fratta W, Fadda P (2009) Baclofen prevents drug-induced reinstatement of extinguished nicotine-seeking behaviour and nicotine place preference in rodents. Eur Neuropsychopharmacol: J European College Neuropsychopharmacol 19:487-498
37. Flannery BA, Garbutt JC, Cody MW, Renn W, Grace K, Osborne M, Crosby K, Morreale M, Trivette A (2004) Baclofen for alcohol dependence: a preliminary open-label study. Alcohol Clin Exp Res 28:1517-1523
38. Franklin TR, Harper D, Kampman K, Kildea-McCrea S, Jens W, Lynch KG, O'Brien CP, Childress AR (2009) The GABA B agonist baclofen reduces cigarette consumption in a preliminary double-blind placebo-controlled smoking reduction study. Drug Alcohol Depend 103:30-36
39. Fucito LM, Park A, Gulliver SB, Mattson ME, Gueorguieva RV, O'Malley SS (2012) Cigarette smoking predicts differential benefit from naltrexone for alcohol dependence. Biol Psychiatry 72:832-838
40. Funk D, Marinelli PW, Le AD (2006) Biological processes underlying co-use of alcohol and nicotine: neuronal mechanisms, crosstolerance, and genetic factors. Alcohol Research Health: J National Institute Alcohol Abuse Alcoholism 29:186-192
41. Garbutt JC, Kampov-Polevoy AB, Gallop R, Kalka-Juhl L, Flannery BA (2010) Efficacy and safety of baclofen for alcohol dependence: a randomized, double-blind, placebo-controlled trial. Alcohol Clin Exp Res 34:1849-1857
42. Grant BF, Hasin DS, Chou SP, Stinson FS, Dawson DA (2004) Nicotine dependence and psychiatric disorders in the United States: results from the national epidemiologic survey on alcohol and related conditions. Arch Gen Psychiatry 61:1107-1115
43. Gueorguieva R, Mallinckrodt C, Krystal JH (2011) Trajectories of depression severity in clinical trials of duloxetine: insights into antidepressant and placebo responses. Arch Gen Psychiatry 68:1227-1237
44. Harrison EL, Hinson RE, McKee SA (2009) Experimenting and daily smokers: episodic patterns of alcohol and cigarette use. Addict Behav 34:484-486
45. Hintz T, Mann K (2007) Long-term behavior in treated alcoholism: Evidence for beneficial carry-over effects of abstinence from smoking on alcohol use and vice versa. Addict Behav 32:3093-3100
46. Hurt RD, Offord KP, Croghan IT, Gomez-Dahl L, Kottke TE, Morse RM, Melton LJ 3rd (1996) Mortality following inpatient addictions treatment. Role of Tobacco Use in a Community-Based Cohort. JAMA: J Am Med Assoc 275:1097-1103
47. Janak PH, Michael Gill T (2003) Comparison of the effects of allopregnanolone with direct GABAergic agonists on ethanol self-administration with and without concurrently available sucrose. Alcohol 30:1-7
48. Jimenez-Ruiz C, Berlin I, Hering T (2009) Varenicline: a novel pharmacotherapy for smoking cessation. Drugs 69:1319-1338
49. Johnson BA, Ait-Daoud N, Akhtar FZ, Javors MA (2005) Use of oral topiramate to promote smoking abstinence among alcohol-dependent smokers: a randomized controlled trial. Arch Intern Med 165:1600-1605
50. Knapp DJ, Overstreet DH, Breese GR (2007) Baclofen blocks expression and sensitization of anxiety-like behavior in an animal model of repeated stress and ethanol withdrawal. Alcohol Clin Exp Res 31: 582-595
51. Leggio L, Garbutt JC, Addolorato G (2010) Effectiveness and safety of baclofen in the treatment of alcohol dependent patients. CNS Neurological Disorders Drug Targets 9:33-44
52. Leggio L, Ferrulli A, Zambon A, Caputo F, Kenna GA, Swift RM, Addolorato G (2012) Baclofen promotes alcohol abstinence in alcohol dependent cirrhotic patients with hepatitis C virus (HCV) infection. Addict Behav 37:561-564
53. Leggio L, Zywiak WH, McGeary JE, Edwards S, Fricchione SR, Shoaff JR, Addolorato G, Swift RM, Kenna GA (2013) A human laboratory pilot study with baclofen in alcoholic individuals. Pharmacol Biochem Behav 103:784-791
54. Lewis-Esquerre JM, Colby SM, Tevyaw TO, Eaton CA, Kahler CW, Monti PM (2005) Validation of the timeline follow-back in the assessment of adolescent smoking. Drug Alcohol Depend 79:33-43
55. Liang JH, Chen F, Krstew E, Cowen MS, Carroll FY, Crawford D, Beart PM, Lawrence AJ (2006) The GABA(B) receptor allosteric modulator CGP7930, like baclofen, reduces operant self-administration of ethanol in alcohol-preferring rats. Neuropharmacology 50:632-639
56. Litten RZ, Ryan ML, Fertig JB, Falk DE, Johnson B, Dunn KE, Green AI, Pettinati HM, Ciraulo DA, Sarid-Segal O, Kampman K, Brunette MF, Strain EC, Tiouririne NA, Ransom J, Scott C, Stout R, N.S.G (2013) A double-blind, placebo-controlled trial assessing the efficacy of varenicline tartrate for alcohol dependence. J Addiction Medicine 7:277-286
57. Lobina C, Carai MA, Froestl W, Mugnaini C, Pasquini S, Corelli F, Gessa GL, Colombo G (2011) Activation of the GABA(B) Receptor prevents nicotine-induced locomotor stimulation in mice. Frontiers Psychiatry 2:76
58. Lyon JE, Khan RA, Gessert CE, Larson PM, Renier CM (2011) Treating alcohol withdrawal with oral baclofen: a randomized, double-blind, placebo-controlled trial. J Hosp Med: Off Publication Soc Hosp Med 6:469-474
59. Maccioni P, Serra S, Vacca G, Orru A, Pes D, Agabio R, Addolorato G, Carai MA, Gessa GL, Colombo G (2005) Baclofen-induced reduction of alcohol reinforcement in alcohol-preferring rats. Alcohol 36:161-168
60. Maccioni P, Bienkowski P, Carai MA, Gessa GL, Colombo G (2008a) Baclofen attenuates cue-induced reinstatement of alcohol-seeking behavior in Sardinian alcohol-preferring (sP) rats. Drug Alcohol Depend 95:284-287
61. Maccioni P, Fantini N, Froestl W, Carai MA, Gessa GL, Colombo G (2008b) Specific reduction of alcohol's motivational properties by the positive allosteric modulator of the GABAB receptor, GS39783 - comparison with the effect of the GABAB receptor direct agonist, baclofen. Alcohol Clin Exp Res 32:1558-1564
62. Markou A, Paterson NE, Semenova S (2004) Role of gamma-aminobutyric acid (GABA) and metabotropic glutamate receptors in nicotine reinforcement: potential pharmacotherapies for smoking cessation. Ann N YAcad Sci 1025:491-503
63. Monti PM, Binkoff JA, Abrams DB, Zwick WR, Nirenberg TD, Liepman MR (1987) Reactivity of alcoholics and nonalcoholics to drinking cues. J Abnorm Psychol 96:122-126
64. Monti PM, Rohsenow DJ, Hutchison KE, Swift RM, Mueller TI, Colby SM, Brown RA, Gulliver SB, Gordon A, Abrams DB (1999) Naltrexone's effect on cue-elicited craving among alcoholics in treatment. Alcohol Clin Exp Res 23:1386-1394
65. Monti PM, Rohsenow DJ, Hutchison KE (2000) Toward bridging the gap between biological, psychobiological and psychosocial models of alcohol craving. Addiction 95(Suppl 2):S229-S236
66. Monti PM, Rohsenow DJ, Swift RM, Gulliver SB, Colby SM, Mueller TI, Brown RA, Gordon A, Abrams DB, Niaura RS, Asher MK (2001) Naltrexone and cue exposure with coping and communication skills training for alcoholics: treatment process and 1-year outcomes. Alcohol Clin Exp Res 25:1634-1647
67. Murschall A, Hauber W (2006) Inactivation of the ventral tegmental area abolished the general excitatory influence of Pavlovian cues on instrumental performance. Learning Memory 13:123-126
68. Paterson NE, Froestl W, Markou A (2004) The GABAB receptor agonists baclofen and CGP44532 decreased nicotine self-administration in the rat. Psychopharmacology (Berl) 172:179-186
69. Peloquin MP, Hecimovic K, Sardinha J, Stewart SH, Barrett SP (2013) The effect of snus on alcohol-related cigarette administration in dependent and non-dependent smokers. Pharmacol Biochem Behav 114-115:97-102
70. Rohsenow DJ, Monti PM, Hutchison KE, Swift RM, Colby SM, Kaplan GB (2000) Naltrexone's effects on reactivity to alcohol cues among alcoholic men. J Abnorm Psychol 109:738-742
71. Romberger DJ, Grant K (2004) Alcohol consumption and smoking status: the role of smoking cessation. Biomed Pharmacother = Biomedecine and Pharmacotherapie 58:77-83
72. Schlaepfer IR, Hoft NR, Ehringer MA (2008) The genetic components of alcohol and nicotine co-addiction: from genes to behavior. Curr Drug Abuse Rev 1:124-134
73. Skinner HA, Allen BA (1982) Alcohol dependence syndrome: measurement and validation. J Abnorm Psychol 91:199-209
74. Sobell LC, Sobell MB, Leo GI, Cancilla A (1988) Reliability of a timeline method: assessing normal drinkers' reports of recent drinking and a comparative evaluation across several populations. Br J Addict 83:393-402
75. Sobell LC, Sobell MB, Kozlowski LT, Toneatto T (1990) Alcohol or tobacco research versus alcohol and tobacco research. Br J Addict 85:263-269
76. Stout RL, Wirtz PW, Carbonari JP, Del Boca FK (1994) Ensuring balanced distribution of prognostic factors in treatment outcome research. J Stud Alcohol Suppl 12:70-75
77. Tizabi Y, Copeland RL Jr, Louis VA, Taylor RE (2002) Effects of combined systemic alcohol and central nicotine administration into ventral tegmental area on dopamine release in the nucleus accumbens. Alcohol Clin Exp Res 26:394-399
78. Vangeli E, Stapleton J, Smit ES, Borland R, West R (2011) Predictors of attempts to stop smoking and their success in adult general population samples: a systematic review. Addiction 106:2110-2121
79. Walker BM, Koob GF (2007) The gamma-aminobutyric acid-B receptor agonist baclofen attenuates responding for ethanol in ethanol-dependent rats. Alcohol Clin Exp Res 31:11-18
80. Weiss RD, O'Malley SS, Hosking JD, Locastro JS, Swift R, Group, C.S.R (2008) Do patients with alcohol dependence respond to placebo? Results from the COMBINE Study. J Stud Alcohol Drugs 69:878-884
81. White KD (1977) Salivation: a review and experimental investigation of major techniques. Psychophysiology 14:203-212
82. Yoshida M, Yokoo H, Tanaka T, Emoto H, Tanaka M (1994) Opposite changes in the mesolimbic dopamine metabolism in the nerve terminal and cell body sites induced by locally infused baclofen in the rat. Brain Res 636:111-114